IDEAYA holds annual meeting, elects directors, appoints Hata Chairman and Rosen Lead Director

IDEAYA Biosciences, Inc.

All three Class I director nominees elected: Hata (70.5M for), Hampton (56.7M for), Mackey (70.3M for).
Ratification of PwC as independent auditor for 2026 passed with 82.6M votes in favor.
Advisory say-on-pay proposal approved with 64.3M for, 8.3M against, 10.1M broker non-votes.
Board elected Yujiro S. Hata as Chairman and Terry Rosen, Ph.D. as Lead Independent Director, effective June 16.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.